RELATED PARTY TRANSACTIONS RELATED PARTY TRANSACTIONS

3 Months Ended

Mar. 31, 2025

Related Party Transactions [Abstract]

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS

Prior to March 18, 2025, we had an investment in Medalogix, a healthcare predictive data and analytics company, which was accounted for under the equity method of accounting. We incurred costs of approximately $2.7 million during the period January 1, 2025 through March 17, 2025 and $2.9 million during the three-month period ended March 31, 2024 in connection with our usage of Medalogix's analytics platforms.

Effective March 18, 2025, we have an investment in an entity that includes Medalogix as well as a healthcare referral and workflow management company which is accounted for under the equity method of accounting (see Note 3 - Investments for additional information). We incurred costs of approximately $0.6 million during the period March 18, 2025 through March 31, 2025 in connection with our usage of these platforms.

We have an investment in a technology-enabled clinician sourcing application, which is accounted for under the cost method of accounting. We incurred costs of approximately $0.8 million and $0.3 million during the three-month periods ended March 31, 2025 and 2024, respectively, in connection with our usage of the technology-enabled clinician sourcing application's services.